Combination of NOS- and PDK-Inhibitory Activity: Possible Way to Enhance Antitumor Effects

We have previously demonstrated a high antitumor potential of NOS inhibitor T1023 (1-isobutanoyl-2-isopropylisothiourea hydrobromide): antitumor antiangiogenic activity in several animal tumor models and its ability to synergistically enhance the antitumor effects of bevacizumab, cyclophosphamide an...

Descripción completa

Detalles Bibliográficos
Autores principales: Filimonova, Marina, Shitova, Anna, Soldatova, Olga, Shevchenko, Ljudmila, Saburova, Alina, Podosinnikova, Tatjana, Surinova, Valentina, Shegay, Petr, Kaprin, Andrey, Ivanov, Sergey, Filimonov, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775993/
https://www.ncbi.nlm.nih.gov/pubmed/35054914
http://dx.doi.org/10.3390/ijms23020730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775993/
https://www.ncbi.nlm.nih.gov/pubmed/35054914
http://dx.doi.org/10.3390/ijms23020730

Ejemplares similares